These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3400510)

  • 21. Paroxysmal dystonia responsive to anticholinergic drugs.
    Micheli F; Fernandez Pardal M; de Arbelaiz R; Lehkuniec E; Giannaula R
    Clin Neuropharmacol; 1987 Aug; 10(4):365-9. PubMed ID: 3503680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A case of type III (adult) GM1-gangliosidosis that improved markedly with trihexyphenidyl].
    Ushiyama M; Hanyu N; Ikeda S; Yanagisawa N
    Rinsho Shinkeigaku; 1986 Mar; 26(3):221-7. PubMed ID: 3089663
    [No Abstract]   [Full Text] [Related]  

  • 23. High dosage anticholinergic therapy in dystonia.
    Fahn S
    Neurology; 1983 Oct; 33(10):1255-61. PubMed ID: 6136938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of respiratory muscles in adult-onset dystonia: a clinical and electrophysiological study.
    Lagueny A; Burbaud P; Le Masson G; Bergouignan FX; Ferrer X; Julien J
    Mov Disord; 1995 Nov; 10(6):708-13. PubMed ID: 8749989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Orobuccal dyskinesia associated with trihexyphenidyl therapy in a patient with Parkinson's disease.
    Hauser RA; Olanow CW
    Mov Disord; 1993 Oct; 8(4):512-4. PubMed ID: 8232363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tardive dyskinesia in chronic schizophrenic inpatients.
    Kua EH; Ang PC; Siew HC
    Singapore Med J; 1982 Feb; 23(1):19-21. PubMed ID: 6126008
    [No Abstract]   [Full Text] [Related]  

  • 27. Pilot study on trihexyphenidyl in the treatment of dystonia in children with cerebral palsy.
    Rice J; Waugh MC
    J Child Neurol; 2009 Feb; 24(2):176-82. PubMed ID: 19182155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Idiopathic dystonia: neuropharmacological study.
    Girotti F; Scigliano G; Nardocci N; Angelini L; Broggi G; Giovannini P; Caraceni T
    J Neurol; 1982; 227(4):239-47. PubMed ID: 6183410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality of life in focal, segmental, and generalized dystonia.
    Page D; Butler A; Jahanshahi M
    Mov Disord; 2007 Feb; 22(3):341-7. PubMed ID: 17216640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ACTH and the effects of anticholinergic drugs in dystonia.
    Sandyk R
    Int J Neurosci; 1989 Mar; 45(1-2):123-6. PubMed ID: 2541093
    [No Abstract]   [Full Text] [Related]  

  • 31. Therapeutic trials in Meige syndrome.
    Gollomp SM; Fahn S; Burke RE; Reches A; Ilson J
    Adv Neurol; 1983; 37():207-13. PubMed ID: 6344589
    [No Abstract]   [Full Text] [Related]  

  • 32. Lack of indication for use of antiparkinson medication. A follow-up study.
    Pecknold JC; Ananth JV; Ban TA; Lehmann HE
    Dis Nerv Syst; 1971 Aug; 32(8):538-41. PubMed ID: 5094160
    [No Abstract]   [Full Text] [Related]  

  • 33. [A case of amoxapine-induced tardive dystonia successfully treated with a low dose anti-cholinergic agent].
    Hayashi Y; Ohyagi Y; Inoue I; Arakawa K; Taniwaki T; Nakagawa M; Kuwabara Y; Yamada T; Kira J
    Rinsho Shinkeigaku; 2000 Apr; 40(4):367-71. PubMed ID: 10967655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evaluation of some anticholinergic drugs used in peptic ulcer therapy as based on radiotelemetric studies].
    Chrostowski K; Jeske J
    Pol Tyg Lek; 1971 Aug; 26(33):1265-7. PubMed ID: 4999276
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hyoscine N-methyl sulfate in general gastro-enterology].
    Félix H; Badrouillard R
    J Med Lyon; 1969 Apr; 50(163):675-6 passim. PubMed ID: 5367023
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparative behavioral and neurochemical activities of cholinergic antagonists in rats.
    Bymaster FP; Heath I; Hendrix JC; Shannon HE
    J Pharmacol Exp Ther; 1993 Oct; 267(1):16-24. PubMed ID: 7901390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of dystonia on quality of life and health in a Swedish population.
    Zetterberg L; Aquilonius SM; Lindmark B
    Acta Neurol Scand; 2009 Jun; 119(6):376-82. PubMed ID: 19016658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meige syndrome: relief on high-dose anticholinergic therapy.
    Duvoisin RC
    Clin Neuropharmacol; 1983 Mar; 6(1):63-6. PubMed ID: 6850651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. "Off" painful dystonia in Parkinson's disease treated with botulinum toxin.
    Pacchetti C; Albani G; Martignoni E; Godi L; Alfonsi E; Nappi G
    Mov Disord; 1995 May; 10(3):333-6. PubMed ID: 7651452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical trial of a new synthetic anticholinergic: 1290 CERM].
    Herne N; Parneix Y
    Mars Med; 1969; 106(7):628-30. PubMed ID: 5399370
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.